Abrogation by chemotherapy of T-cell antigen expression in B-cell chronic lymphocytic leukemia.
Perl
A
A
Szigeti
A
A
Gergely
P
P
Feher
J
J
Magyarosi
E
E
Sellyei
M
M
D000368:Aged; D000954:Antigens, Surface / Q000032:analysis*; D000971:Antineoplastic Combined Chemotherapy Protocols; D001402:B-Lymphocytes / Q000276:immunology*; D001761:Bleomycin / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D011241:Prednisone / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000276:immunology*; D014750:Vincristine / Q000627:therapeutic use
D000954:Antigens, Surface; D001761:Bleomycin; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone